Valion Bio Inc. (VBIO) Live Share Price, Invest From India

Valion Bio Inc. Stock Performance

as on August 1, 2026 at 2:15 pm IST

Day's Low
Day's High
$0.26
Day's Price Range
$0.36
$0.31
16.13%
Downside
16.13%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.31
100.00%
Downside
-100.00%
Upside

Valion Bio Inc. share price movements today

Previous Close: $0.28
Open: $0.30
Volume: 4.4M
Day's Low - High: $0.26 - $0.36

Valion Bio Inc. Historical Returns

1 Month Return: -40.21 %
3 Month Return: -66.3 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Valion Bio Inc. Stock Fundamentals & Key Indicators

Check Valion Bio Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.2M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-182.22%

Valion Bio Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Valion Bio Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Valion Bio Inc.	NA	$1.2M	NA	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$40.9B	554.78%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$122.3B	136.68%	28.66	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$76.0B	32.72%	16.98	29.65%	NA

Indian Investors' Interest in Valion Bio Inc. Stock

Search interest for Valion Bio Inc. Stock has increased by 4% in the last 30 days, reflecting an upward trend in search activity.

Time period: July 2, 2026 to August 1, 2026

Change:4% versus previous 30 day period

Valion Bio Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	0	-	0	0	0	0
Gross Profit	0	0	0	0	-	-
Operating Income	-1	-1	-1	0	-1	-1
EBITDA	-	-	-	0	-	0
Interest Expense	-	-	-	0	-	0
Depreciation	0	0	0	-	0	0
Income Before Tax	-1	-1	-1	0	-1	-1
Income Tax Expense	-	-	-	-	-	-
Net Income	-1	-1	-1	0	-2	-1
Net Profit Margin	-820.56%	0.00%	-2245.35%	-81.33%	943.38%	-200.32%

Valion Bio Inc. Annual Profit & Loss

All numbers in Millions USD

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	-	-	1	1	-	-
Gross Profit	0	0	-	-	0	0	0	-
Operating Income	-	-	-	-	-10	-8	-4	-7
EBITDA	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	0
Depreciation	-	-	-	-	0	0	0	0
Income Before Tax	-	-	-	-	-10	-8	-4	-7
Income Tax Expense	-	-	-	-	-	-	-	-
Net Income	-4	-13	-4	0	-10	-8	-5	-8
Net Profit Margin	-4207.22%	-5080.21%	0.00%	0.00%	-548.70%	-701.02%	0.00%	0.00%

Valion Bio Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2021	Jun 2021	Sep 2021	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	0	0	0	-1	-1	-1	4	-2	-1
Operating Cash Flow	0	0	0	-1	0	-1	0	-2	0
Investing Cash Flow	-	-	-	-	-	-	0	-	-
Financing Cash Flow	-	-	0	1	0	2	0	11	0
Change in Cash	0	0	0	0	-1	0	0	9	0

Valion Bio Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-4	-4	0	-8	-10	-8	-5	-8
Operating Cash Flow	-1	-2	-3	-1	-	-8	-8	-5	-6
Investing Cash Flow	-	-	0	-	-	-	-	-	-
Financing Cash Flow	2	2	8	0	-	0	8	4	18
Change in Cash	1	0	-3	-1	-	-9	0	-1	10

Global Institutional Holdings in Valion Bio Inc.

Funds	Holdings
Bank of America Corp	0%
HRT FINANCIAL LLC	1.35%
XTX Topco Ltd	0.33%
UBS Group AG	0.08%
Caitong International Asset Management Co., Limited.	0%

See all

Insights on Valion Bio Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 412.0% return, outperforming this stock by 502.4%
NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 495.3% return, outperforming this stock by 594.9%
NEGATIVE IMPACT
Price Dip
In the last 1 month, VBIO stock has moved down by -40.2%

About Valion Bio Inc.

Valion Bio, Inc. operates as a late-stage biopharmaceutical company. Its lead drug candidate is Entolimod, a TLR5 agonist that is in late-stage development to treat acute radiation syndrome. The company's pipeline also comprises Entolimod to treat Neutropenia and lymphocyte exhaustion; and Entolasta, an immunologically optimized variant of Entolimod for chronic applications, such as immunosenescence. In addition, it offers CDMO services. The company was formerly known as Tivic Health Systems, Inc. and changed its name to Valion Bio, Inc. in April 2026. The company was incorporated in 2016 and is based in San Antonio, Texas.

Organisation	Valion Bio Inc.
Headquarters	1305 E. Houston Street, San Antonio, TX, United States, 78205
Industry	Biotechnology
CEO	Ms. Melinda Lackey
E-voting on shares	Click here to vote

Key Management of Valion Bio Inc.

Name	Title
Ms. Melinda Lackey	General Counsel & Senior Vice President of Legal Affairs

FAQs

What is Valion Bio Inc. share price today?

Valion Bio Inc. share price today is $0.31 as on August 1, 2026 at 8:45 am IST at the close of the market. Valion Bio Inc. share today touched a day high of $0.36 and a low of $0.26.

What is the 52 week high and 52 week low for Valion Bio Inc. share?

Valion Bio Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Valion Bio Inc. stock price today i.e. August 1, 2026 at 8:45 am IST is closed at $0.31,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Valion Bio Inc.'s market capitalisation today?

Valion Bio Inc. market capitalisation is $0.00T as on August 1, 2026 at 8:45 am IST.

How to invest in Valion Bio Inc. Stock (VBIO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Valion Bio Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Valion Bio Inc. Shares that will get you 4.8387 shares as per Valion Bio Inc. share price of $0.31 per share as on August 1, 2026 at 8:45 am IST.

What is the minimum amount required to buy Valion Bio Inc. Stock (VBIO) from India?

Indian investors can start investing in Valion Bio Inc. (VBIO) shares with as little as ₹95.38 or $1 (as of August 1, 2026 at 1:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.80 in Valion Bio Inc. stock (as per the Rupee-Dollar exchange rate as on August 1, 2026 at 1:39 pm IST). Based on Valion Bio Inc. share’s latest price of $0.31 as on August 1, 2026 at 8:45 am IST, you will get 32.2581 shares of Valion Bio Inc.. Learn more about fractional shares .